References
- Zeman E. M., Brown J. M., Lemmon M. J., Hirst V. K., Lee W. W. SR4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology, Biology and Physics 1986; 12: 1239–1242
- Zeman E. M., Hirst V. K., Lemmon M. J., Brown J. M. Enhancement of radiation-induced tumour cell killing by the hypoxic cell toxin SR4233. Radiotherapy and Oncology 1988; 12: 209–218
- Zeman E. M., Brown J. M. Pre- and post-irradiation radiosensitization by SR4233. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 967–971
- Laderoute K., Wardman P., Rauth A. M. Molecular mechanisms for the hypoxia dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxidc (SR4233). Biochemical Pharmacology 1988; 37: 1487–1495
- Laderoute K., Wardman P., Rauth A. M. Identification of two major reduction products of the hypoxic cell toxin 3-amino-1,2,4-benzotriazine-1,4-dioxide. Biochemical Pharmacology 1986; 35: 3417–3420
- Tocher J. H., Virk N. S., Edwards D. I. Electrochemical studies and DNA damaging effects of the benzotriazine-N-oxides. Biochemical Pharmacology 1990; 39: 781–786
- Zeman E. M., Baker M. A., Lemmon M. J., Pearson C. M., Adams J. A., Brown J. M., Lee W. W., Tracy M. Structure-activity relationships for benzotriazine di-N-oxides. International Journal of Radiation Oncology. Biology and Physics 1989; 16: 977–981
- Tocher J. H., Virk N. S., Edwards D. I. DNA damaging effects and voltammetric studies on the hypoxic cell toxin SR4233 as a funtion of pH. Biochemical Pharmacology 1990, (in press)
- Rowley D. A., Knight R. C., Skolimowski I. M., Edwards D. I. The effect of nitroheterocyclic drugs on DNA: an in vitro model of cytotoxicity. Biochemical Pharmacology 1979; 28: 3009–3013
- Edwards D. I., Knight R. C., Zahoor A. DNA damage induced by reductively activated nitromidazoles - pH effects. International Journal of Radiation Oncology. Biology and Physics 1986; 12: 1207–1209